Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.

MLA

Liu, Yating, et al. “Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.” ACS Applied Bio Materials, vol. 2, no. 3, Mar. 2019, pp. 1241–54. EBSCOhost, https://doi.org/10.1021/acsabm.8b00811.

APA

Liu, Y., Yao, L., Cao, W., Liu, Y., Zhai, W., Wu, Y., Wang, B., Gou, S., Qin, Y., Qi, Y., Chen, Z., & Gao, Y. (2019). Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy. ACS Applied Bio Materials, 2(3), 1241–1254. https://doi.org/10.1021/acsabm.8b00811

Chicago

Liu, Yating, Lintong Yao, Wenpeng Cao, Yajing Liu, Wenjie Zhai, Yahong Wu, Binglin Wang, et al. 2019. “Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.” ACS Applied Bio Materials 2 (3): 1241–54. doi:10.1021/acsabm.8b00811.